NanoViricides Inc. (NNVC)

[JG36]

It's nice to see the price finally north of 0.50 again. Although frankly, whether it goes up or down for the next few months isn't really what matters. What matters is the news that will either drive the stock to 0 or send it north of $10 - tangible progress towards the clinical trials and the clinical trials themselves. The first news of this sort will be the announcement that tox studies have finally begun, and that might take as long as September. Of course the results of the tox studies are what really matter, not the start, but at least the start will be further evidence that NNVC really means it this time.